Tensha Therapeutics, Inc. (Tensha)

Oncology Corporate Profile

HQ Location

55 Cambridge Parkway, Suite 102
Cambridge, MA 2142

Company Description

Tensha Therapeutics is developing small molecule bromodomain inhibitors, a new class of epigenetic modulators of gene expression, to treat cancer and other serious disorders.

Website: http://tenshatherapeutics.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
TEN-010BET inhibitorAcute Myelogenous Leukemia (AML)I
TEN-010BET inhibitorMyelodysplastic Syndrome (MDS)I

View additional information on product candidates here »

Source: http://tenshatherapeutics.com

Recent News Headlines

There are no news items to display